Renaissance Technologies
DSCI

Renaissance Technologies’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Renaissance Technologies’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-629,600
Closed -$3.27M – 3634
2016
Q4 		$3.27M Sell
629,600
-8,400
-1% -$39.5K 0.01% 1944
2016
Q3 		$2.98M Buy
638,000
+58,300
+10% +$272K 0.01% 1956
2016
Q2 		$2.28M Buy
579,700
+37,900
+7% +$142K ﹤0.01% 2126
2016
Q1 		$1.68M Buy
541,800
+102,500
+23% +$343K ﹤0.01% 2326
2015
Q4 		$2.01M Buy
439,300
+158,300
+56% +$751K ﹤0.01% 2108
2015
Q3 		$1.32M Sell
281,000
-100,907
-26% -$651K ﹤0.01% 2228
2015
Q2 		$2.73M Buy
381,907
+240,299
+170% +$1.81M 0.01% 1854
2015
Q1 		$1.2M Buy
141,608
+125,985
+806% +$1.07M ﹤0.01% 2213
2014
Q4 		$145K Buy
+15,623
New +$136K ﹤0.01% 2741
2014
Q2 		– Sell
-95,281
Closed -$1.21M – 3225
2014
Q1 		$1.21M Buy
+95,281
New +$1.23M ﹤0.01% 1998

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Renaissance Technologies's DSCI Position: Q1 2017 in Review

Renaissance Technologies sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 629,600 shares — an estimated $3.27M sold.

Renaissance Technologies first reported a position in DSCI in Q1 2014 and held it in 10 quarters. The position peaked at $3.27M in Q4 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Renaissance Technologies reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • Renaissance Technologies sold 629,600 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $3.27M.
  • Renaissance Technologies first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 10 quarters.
  • Renaissance Technologies's Derma Sciences, Inc. Common Stock (DE) position peaked at $3.27M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.